髂股静脉慢性闭塞支架置入中50%狭窄标准的效用评估
本研究回顾性纳入480例因症状性慢性髂股静脉闭塞行支架置入的患者,按IVUS测定的狭窄程度分为<50%低级别狭窄组(283肢)和≥50%高级别狭窄组(197肢)。结论认为狭窄程度不影响临床改善,即使狭窄<50%且保守治疗失败的症状患者也应考虑支架置入。
要点
- IVUS测定的髂股静脉狭窄程度不影响支架置入后的临床症状、生活质量改善及支架通畅率。
- 狭窄<50%的患者若症状影响生活质量且保守治疗失败,仍可考虑支架置入。
- 复合慢性静脉功能不全评分(CCVIS)可能有助于预测支架置入后改善,但需进一步研究。
核心结论
- IVUS测定的髂股静脉狭窄程度不影响初始临床表现、CEAP临床分级、仰卧位足部静脉压、临床改善、生活质量改善、支架通畅率或再干预率。
- 对于保守治疗失败且症状影响生活质量的患者,即使狭窄程度<50%也应考虑纠正闭塞。
- CCVIS可能有助于预测支架置入后改善,但需进一步研究。
研究设计与样本
- 回顾性综述了2014年至2017年连续480例(480肢)因症状性慢性髂股静脉闭塞影响生活质量而初次置入髂股静脉支架的患者。
- 使用IVUS测定的正常最小管腔面积(股总静脉125 mm²、髂外静脉150 mm²、髂总静脉200 mm²)将肢体分为<50%狭窄(低级别狭窄组,LGS)和≥50%狭窄(高级别狭窄组,HGS)。
主要发现
- 480肢中LGS组283肢,HGS组197肢;两组均以女性、左侧、血栓后综合征为主。
关键数值与推荐
- IVUS测定的正常最小管腔面积:股总静脉125 mm²、髂外静脉150 mm²、髂总静脉200 mm²。
- VCSS范围0-27分。
- 基线CCVIS≥84.5、≥86.9、≥105.3分别对应大多数肢体支架置入后30、40、50分改善。
临床怎么用
- 对于症状影响生活质量且保守治疗失败的慢性髂股静脉闭塞患者,即使IVUS测定的狭窄程度<50%,也应考虑支架置入。
- 支架置入后的临床改善、生活质量和支架通畅率与狭窄程度无关,决策不应仅依赖50%狭窄阈值。
- CCVIS可能有助于预测支架置入后改善,但需进一步研究验证。
局限性
- 回顾性研究设计。
- CCVIS预测价值需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The criterion for venous stenting in symptomatic chronic iliofemoral venous obstruction has been the arbitrary use of stenosis of ≥50%. In the present study, we evaluated the intravascular ultrasound (IVUS)-determined degree of stenosis in patients who had undergone stenting for quality of life (QOL)-impairing symptoms and assessed the utility of the 50% stenosis cutoff. METHODS: A retrospective review of contemporaneously entered electronic medical record data from 480 continuous patients (480 limbs) with initial iliofemoral stents placed (2014 to 2017) for symptomatic chronic iliofemoral venous obstruction impairing their QOL was performed. The IVUS-determined normal minimal luminal areas for the common femoral vein (125 mm), external iliac vein (150 mm), and common iliac vein (200 mm) were used to group limbs as having <50% (low-grade stenosis [LGS]) or ≥50% (high-grade stenosis [HGS]) stenosis. The variables compared included the visual analog scale (VAS) for pain score, venous clinical severity score (VCSS; range, 0-27), ulcer healing, supine foot venous pressures, QOL (20-item chronic venous disease QOL questionnaire), and stent patency. A composite chronic venous insufficiency score (CCVIS) incorporating the VAS score, VCSS, and CIVIQ-20 score for predicting improvement after stenting was evaluated. RESULTS: Of the 480 limbs, 283 and 197 were in the LGS and HGS groups, respectively. A preponderance of women, left laterality, and post-thrombotic syndrome were noted in both groups. At baseline, although no difference was found in the VAS for pain score between groups, the LGS group had a higher VCSS than did the HGS group (P = .05). The baseline median supine foot venous pressure was 15 and 14 mm Hg in the LGS and HGS groups, respectively (P = .17). At 24 months after stenting, the mean VCSS had improved from 6.3 to 4.4 (P < .0001) and from 5.7 to 3.7 (P < .0001) in the LGS and HGS groups, respectively, without significant differences between the two groups (P = .07). A greater prevalence of ulcers was found in the LGS group (18% vs 11%; P = .04), with no differences in healing (P = .41) or recurrence rates (P = .36). The QOL scores had improved in both groups (LGS, from 58 to 37 [P < .0001]; HGS, from 61 to 35 [P < .0001]), without differences between the two groups (P > .3). No significant differences in stent patency or reinterventions rates were found. A baseline CCVIS of ≥84.5, ≥86.9, or ≥105.3 was needed for a 30-, 40-, and 50-point improvement in most limbs after stenting. CONCLUSIONS: The degree of IVUS-determined iliofemoral venous stenosis did not appear to affect the initial clinical presentation, CEAP (clinical, etiologic, anatomic, pathophysiologic) clinical class, supine foot venous pressure, clinical improvement, QOL improvement, stent patency, or reintervention rates after stenting. Patients presenting with QOL-impairing symptoms in whom conservative treatment has failed merit consideration of correction of their obstruction even if the degree of stenosis is <50%. The use of a CCVIS might be helpful but requires further study.
引用
- Jayaraj A, Powell T, Raju S, et al. Utility of the 50% stenosis criterion for patients undergoing stenting for chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34098125. doi:10.1016/j.jvsv.2021.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。